Gerresheimer AG - Board/Management Information 2018

News Details

Corporate | 11 October 2018 07:38

Gerresheimer AG: Andreas Schütte steps down from Management Board of Gerresheimer AG

DGAP-News: Gerresheimer AG / Key word(s): Change of Personnel

11.10.2018 / 07:38

The issuer is solely responsible for the content of this announcement.

Andreas Schütte steps down from Management Board of Gerresheimer AG

Duesseldorf, October 11, 2018-Andreas Schütte (56) will step down from the Management Board of Gerresheimer AG at his own request as of February 28, 2019 in order to pursue new career challenges. The Supervisory Board of Gerresheimer AG approved this wish at its meeting yesterday. Andreas Schütte has served on the Management Board of Gerresheimer AG since 2009 with responsibility for the Plastics & Devices and Advanced Technologies Divisions. These responsibilities will be assumed from March 1, 2019 by Dietmar Siemssen, who takes up office as CEO of Gerresheimer AG on November 1, 2018.

“We accept Mr. Schütte’s wish to terminate his contract at his own request ahead of term and thank him for his commitment and service to Gerresheimer AG over what has been almost ten years. With his commitment, Gerresheimer has succeeded in further extending its market-leading international position, notably in North and South America as well as in India. The acquisition of Sensile Medical also added substantially to the Company’s capability portfolio in drug delivery systems. We wish Mr. Schütte every success for the future,” said Dr. Axel Herberg, Chairman of the Supervisory Board of Gerresheimer AG.

About Gerresheimer

Gerresheimer is a leading global partner to the pharma and healthcare industries. The company’s special glass and plastic products contribute to health and well-being. Gerresheimer is a global organization with about 10,000 employees and manufacturing operations in the local markets, close to customers. With plants in Europe, North and South America and Asia Gerresheimer generates revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging products as well as convenient and safe drug delivery systems such as insulin pens, inhalers, micro pumps, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products.

Contact Press Contact Investor Relations

Jens Kürten Severine Camp

Group Senior Director Communication & Marketing Corporate Senior Director Investor Relations

Phone +49 211 6181-250 Phone +49 211 6181-314

Telefax +49 211 6181-241 Telefax +49 211 6181-121

E-Mail [email protected] E-Mail [email protected]

11.10.2018 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de


Language:	English
Company:	Gerresheimer AG
	Klaus-Bungert-Str. 4
	40468 Düsseldorf
	Germany
Phone:	+49-(0)211/61 81-00
Fax:	+49-(0)211/61 81-295
E-mail:	[email protected]
Internet:	http://www.gerresheimer.com
ISIN:	DE000A0LD6E6
WKN:	A0LD6E
Indices:	MDAX (Aktie)
Listed:	Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange